Sonodynamic Activated Nanoparticles with Glut1 Inhibitor and Cystine-containing Polymer Stimulate Disulfidptosis for Improved Immunotherapy in Bladder Cancer
Ke Wang,
No information about this author
Li Li,
No information about this author
Ganghao Liang
No information about this author
et al.
Biomaterials,
Journal Year:
2025,
Volume and Issue:
319, P. 123178 - 123178
Published: Feb. 8, 2025
Language: Английский
Ruthenium(II) Polypyridyl Complexes Containing COUBPY Ligands as Potent Photosensitizers for the Efficient Phototherapy of Hypoxic Tumors
Journal of the American Chemical Society,
Journal Year:
2025,
Volume and Issue:
147(9), P. 7360 - 7376
Published: Feb. 15, 2025
Hypoxia,
a
hallmark
of
many
solid
tumors,
is
linked
to
increased
cancer
aggressiveness,
metastasis,
and
resistance
conventional
therapies,
leading
poor
patient
outcomes.
This
challenges
the
efficiency
photodynamic
therapy
(PDT),
which
relies
on
generation
cytotoxic
reactive
oxygen
species
(ROS)
through
irradiation
photosensitizer
(PS),
process
partially
dependent
levels.
In
this
work,
we
introduce
novel
family
potent
PSs
based
ruthenium(II)
polypyridyl
complexes
with
2,2′-bipyridyl
ligands
derived
from
COUPY
coumarins,
termed
COUBPYs.
Ru-COUBPY
exhibit
outstanding
in
vitro
cytotoxicity
against
CT-26
cells
when
irradiated
light
within
phototherapeutic
window,
achieving
nanomolar
potency
both
normoxic
hypoxic
conditions
while
remaining
nontoxic
dark,
impressive
phototoxic
indices
(>30,000).
Their
ability
generate
Type
I
II
ROS
underpins
their
exceptional
PDT
efficiency.
The
lead
compound
study,
SCV49,
shows
favorable
vivo
pharmacokinetic
profile,
excellent
toxicological
tolerability,
tumor
growth
inhibition
mice
bearing
subcutaneous
tumors
at
doses
as
low
3
mg/kg
upon
deep-red
(660
nm).
These
results
allow
us
propose
SCV49
strong
candidate
for
further
preclinical
development,
particularly
treating
large
tumors.
Language: Английский
Biodegradable iridium coordinated nanodrugs potentiate photodynamic therapy and immunotherapy of lung cancer
Jingyao Li,
No information about this author
Huixi Yi,
No information about this author
Yuanyuan Fu
No information about this author
et al.
Journal of Colloid and Interface Science,
Journal Year:
2024,
Volume and Issue:
680, P. 9 - 24
Published: Oct. 30, 2024
Language: Английский
Ultrasound-responsive nanobubble-mediated sonodynamic therapy sensitizes disulfidptosis in the treatment of liver hepatocellular carcinoma
Ultrasonics Sonochemistry,
Journal Year:
2025,
Volume and Issue:
118, P. 107368 - 107368
Published: April 23, 2025
Disulfidptosis,
a
newly
identified
regulated
cell
death,
is
linked
to
tumor
progression,
particularly
in
cancers
with
elevated
SLC7A11
expression.
This
study
investigates
expression
liver
hepatocellular
carcinoma
(LIHC)
and
evaluates
the
therapeutic
potential
of
ICG@C3F8-KL
nanobubbles
(NBs)
combined
sonodynamic
therapy
(SDT)
for
inducing
disulfidptosis.
Bioinformatics
analysis
TCGA
datasets
revealed
upregulation
LIHC
tissues.
The
synthesized
NBs
exhibited
mean
diameter
156.46
nm
stable
properties,
high
encapsulation
efficiencies
51.32
%
±
0.7
KL
80.15
0.21
ICG.
In
vitro,
NBs,
under
ultrasound,
generated
reactive
oxygen
species
(ROS),
enhancing
cytotoxicity
HepG2
cells
an
IC50
lower
than
alone.
These
also
inhibited
migration
colony
formation,
suggesting
disulfidptosis
induction
via
altered
glucose
uptake
NADP+/NADPH
ratio,
as
well
F-actin
contraction.
vivo,
accumulated
tissues
suppressed
growth
without
significant
toxicity.
Unsupervised
clustering
disulfidptosis-related
genes
cohort
subtypes
distinct
prognoses,
predictive
model
based
on
five
key
was
developed.
conclusion,
effectively
induce
disulfidptosis,
offering
promising
strategy
treatment,
personalized
informed
by
disulfide-associated
gene
signatures.
Language: Английский
A comparative study of PEO-PBO content on the targeting and anti-glioma activity of annonaceous acetogenins-loaded nanomicelles
Hui Ao,
No information about this author
Yao Fu,
No information about this author
Xiangtao Wang
No information about this author
et al.
Colloids and Surfaces B Biointerfaces,
Journal Year:
2024,
Volume and Issue:
244, P. 114176 - 114176
Published: Aug. 30, 2024
Language: Английский
Breaking the deep-red light absorption barrier of iridium(III)-based photosensitizers.
Dalton Transactions,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 30, 2024
Recent
advancements
in
ligand
design
and
fluorophore
functionalization
enable
Ir(
iii
)
photosensitizers
to
achieve
deep-red/near-infrared
absorption,
addressing
challenges
photodynamic
therapy
for
deep-seated
tumors.
Language: Английский
Biodegradable Iridium Coordinated Nanodrugs Potentiate Photodynamic Therapy and Immunotherapy of Lung Cancer
Jingyao Li,
No information about this author
Huixi Yi,
No information about this author
Yuanyuan Fu
No information about this author
et al.
Published: Jan. 1, 2024
Language: Английский
Synthesis, Structure, Spectral, and Electrochemical Properties of New Visible to NIR Absorbing 3-Pyrrolyl BODIPY Derivatives
Organic & Biomolecular Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 3, 2024
This
study
presents
3-pyrrolyl
BODIPY-based
Schiff
base
and
benzothiazole
derivatives
with
tunable
red-to-NIR
properties,
highlighting
a
Re(
i
)
complex
distorted
octahedral
geometry
for
its
potential
in
coordination
chemistry.
Language: Английский